Consolidated Statements of Operations and Comprehensive Loss - USD ($) |
12 Months Ended | |
|---|---|---|
Feb. 28, 2017 |
Feb. 29, 2016 |
|
| Condensed Consolidated Statements Of Operations And Comprehensive Loss | ||
| Revenue | ||
| Operating Expenses | ||
| General and administrative | 6,980,281 | 1,748,044 |
| Research and development | 1,454,440 | 801,666 |
| Depreciation and amortization | 397,445 | 211,845 |
| Cost of reverse merger | 60,571 | |
| Foreign exchange (gain) loss | (18,165) | 14,240 |
| Total operating expenses | 8,814,001 | 2,836,366 |
| Net Loss | (8,814,001) | (2,836,366) |
| Other comprehensive (loss) income- | ||
| Foreign currency translation adjustment | (157,142) | 5,931 |
| Comprehensive Loss | $ (8,971,143) | $ (2,830,435) |
| Loss per share - Basic and Diluted | $ (0.28) | $ (0.10) |
| Weighted average common shares outstanding - Basic and Diluted | 31,102,004 | 27,359,605 |